2 studies found for: ANGIOMA, HEREDITARY NEUROCUTANEOUS
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
|2||Active, not recruiting||
Stereotactic Body Radiotherapy for Spine Tumors
† Study has passed its completion date and status has not been verified in more than two years.